-A +A
Text Size
Home » News and Research » Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer News and Research

Too little blood-borne adiponectin may boost risk of thyroid cancer
10/03/2011 - Research conducted by a team of Greek and American endocrinologists has revealed that too little of the metabolic protein adiponectin in the blood may increase the likelihood of thyroid cancer, while higher levels may entail a lower-than-average risk of the disease.
Article reviews rare cardiac metastases of thyroid cancer
08/17/2011 - Even among the most virulent types of metastatic thyroid cancer, the carcinoma is very unlikely to migrate to the heart, which is why a team of Australian researchers recently compiled a list of all cardiac metastases of thyroid tumors (CMTTs) recorded in the last 130 years.
Case study examines spread of papillary thyroid cancer to bones
08/12/2011 - Papillary thyroid cancer (PTC) is generally considered the most benign of all thyroid carcinomas, with a low risk of metastasis, which is one reason why a researcher from Georgetown University published a case study of a patient whose PTC was found to have spread to many skeletal sites in her body.
Protein tests predict recurrence of papillary or follicular thyroid cancer
06/03/2011 - Some experts are unsure of the ability of protein-based tests to predict the return of thyroid carcinomas, which is why a team of scientists recently monitored the recurrence of papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) among patients given serum thyroglobulin (Tg) assays.
Scientists explore how thyroid cancer metastasizes, often staying dormant for years
05/23/2011 - Distant metastases of thyroid cancer can dramatically reduce a patient's likelihood of survival, which is one reason why a scientist at the Ohio State University College of Medicine recently reviewed the current clinical understanding of how thyroid carcinoma cells migrate.
Study establishes epidemiology of thyroid cancer by type, demographic group
04/19/2011 - Researchers from the National Cancer Institute (NCI) and several U.S. universities recently analyzed state-based thyroid cancer data in order to determine the incidence of each variety of the disease among American demographic groups.
Study: DNA-transcribing protein affects severity of anaplastic thyroid cancer
03/18/2011 - Anaplastic thyroid cancer is one of the most dangerous varieties of thyroid carcinoma, but a new study may have found at least one genetic controller that determines its severity.
Combination therapy may be more effective at treating thyroid cancer than chemo alone
09/30/2010 - According to research presented at this year's International Thyroid Congress, combination therapies may be superior to chemotherapy alone in the overall survival rates of thyroid cancer patients, Endocrine Today reports.
New drug may increase survival rates of anaplastic thyroid cancer patients
09/27/2010 - At the International Thyroid Congress in Paris, researchers from the University of Pisa in Italy explained their research on a study of Zybrestat in the treatment of anaplastic thyroid cancer.
Mayo Clinic creates four new anaplastic thyroid cancer cell lines for research
08/27/2010 - Several years ago, scientists from the Mayo Clinic discovered that the laboratory samples of anaplastic thyroid cancer (ATC) that they were using for research were from some other type of cancer. The researchers then set out to create a new set of laboratory ATC cells, derived from tumors donated by patients.
Mayo Clinic: Rarely used anaplastic thyroid cancer treatment highly effective
07/30/2010 - Doctors at the Mayo Clinic have said that a new approach to anaplastic thyroid cancer, which is a rare malignancy, has produced significant results, although it has only been used on a small group of patients.